Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ibio Inc
IBIO
Healthcare
Biotechnology
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu...
technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. Its pipeline includes IBIO-101, TROP-2 x CD3, MUC16, EGFRvIII, CCR8, and Target 5. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSEAM:IBIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(7)
•••
Securecheck1
X
View Profile
View Bullboard History
Comment by
Securecheck1
on Oct 18, 2023 7:25pm
RE:Another sucking penny stock
It's really easy to have two accounts here isn't it patience is key... But really hard to cancel...
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 06, 2023 2:00pm
iBio Expands Tech Stack with EngageTx(TM); Adds TROP-2 Bispe
Breaking News: $IBIO iBio Expands Tech Stack with EngageTx(TM); Adds TROP-2 Bispecific to Development PipelineBRYAN, Texas and SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
Peng26
X
View Profile
View Bullboard History
Post by
Peng26
on Apr 13, 2023 5:19am
This is Going to Change Society
FSD Pharma Inc is about to launch this breakthrough product!! This is Going to Change Society:{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=GTz2294l4KA|(fs
...more
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on Apr 13, 2023 3:13am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(28)
•••
satchmo6
X
View Profile
View Bullboard History
Comment by
satchmo6
on Feb 18, 2023 6:55pm
RE:A PENNY FARFLUNG
Some come here to talk some witt but others come to lQQk and s*** and smile
(28)
•••
satchmo6
X
View Profile
View Bullboard History
Post by
satchmo6
on Feb 18, 2023 6:52pm
the Rothchilds took a hit
check the 15 year chart my cost was in the 2 --3 dollar range
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Comment by
CamelHurder
on Oct 10, 2022 10:15am
RE:iBio Acquires FastPharming Manufacturing Facility®
local pharma makes GOOD
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Post by
CamelHurder
on Oct 10, 2022 10:12am
A PENNY FARFLUNG
Such a deal....BRO
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on Jul 15, 2022 8:49pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(100)
•••
GajjarDr
X
View Profile
View Bullboard History
Comment by
GajjarDr
on Jun 17, 2022 3:33pm
RE:If Your Wondering Why...
This is pretty interesting. Why would not FDA approve the pure form I wonder now?
(17)
•••
Unimaginatively
X
View Profile
View Bullboard History
Post by
Unimaginatively
on Jun 17, 2022 3:28pm
If Your Wondering Why...
there hasn't been much KanCer cures released... its because is a vitamin b17 deficiency... can get it in apricot kernels. Health Canada says to eat no more than 3 per day. Check out Edward Griffin
...more
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on Jun 03, 2022 4:19am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on Jun 01, 2022 11:54pm
FSD Pharma Files Investigational New Drug Application “IND”
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on May 10, 2022 11:55pm
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(1)
•••
Rebecca
X
View Profile
View Bullboard History
Post by
Rebecca
on May 01, 2022 11:15pm
Lucid-MS for Multiple Sclerosis Treatment
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >